NKTR - Nektar Therapeutics

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.31B
Enterprise Value 36.97B
Trailing P/E 8.96
Forward P/E 1-33.70
PEG Ratio (5 yr expected) 1-1.79
Price/Sales (ttm)6.05
Price/Book (mrq)4.47
Enterprise Value/Revenue 35.07
Enterprise Value/EBITDA 67.23

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 65.69%
Operating Margin (ttm)69.35%

Management Effectiveness

Return on Assets (ttm)42.71%
Return on Equity (ttm)96.87%

Income Statement

Revenue (ttm)1.37B
Revenue Per Share (ttm)8.49
Quarterly Revenue Growth (yoy)3,044.70%
Gross Profit (ttm)278.56M
EBITDA 964.56M
Net Income Avi to Common (ttm)902.71M
Diluted EPS (ttm)5.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.82B
Total Cash Per Share (mrq)10.57
Total Debt (mrq)246.08M
Total Debt/Equity (mrq)13.23
Current Ratio (mrq)19.67
Book Value Per Share (mrq)10.79

Cash Flow Statement

Operating Cash Flow (ttm)919.85M
Levered Free Cash Flow (ttm)602.48M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.02
52-Week Change 3101.87%
S&P500 52-Week Change 37.95%
52 Week High 3111.36
52 Week Low 322.92
50-Day Moving Average 357.43
200-Day Moving Average 365.06

Share Statistics

Avg Vol (3 month) 32.02M
Avg Vol (10 day) 31.6M
Shares Outstanding 5172.47M
Float 171.32M
% Held by Insiders 10.89%
% Held by Institutions 194.02%
Shares Short (Sep 28, 2018) 416.25M
Short Ratio (Sep 28, 2018) 48.11
Short % of Float (Sep 28, 2018) 418.27%
Short % of Shares Outstanding (Sep 28, 2018) 49.42%
Shares Short (prior month Aug 31, 2018) 415.66M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Aug 23, 2000